首页 > 最新文献

Cardiovascular Journal最新文献

英文 中文
Outcome in Cardiac Electrophysiology and Radiofrequency Ablation of Atrioventricular Reciprocating Tachycardia - A Single Center Experience 单中心经验:房室往复式心动过速的心脏电生理和射频消融术的预后
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61906
P. Bala, M. A. Ali, A. Reza, S. Talukder, S. Munwar, T. Ahmed, Kazi Atiqur Rahman, M. Khan, Nighat Islam, A. H. Bhuiyan, A. Islam, D. Afroz, Abeeda Tasnim Reza, Md Arifur Rahman, Aparajita Karim, Kanu Bala, M. Chaudhary
Background: Radiofrequency catheter ablation is a curative modality of treatment for paroxysmal supraventricular tachycardia. The aim of our study was to evaluate our experience of electrophysiology procedures and radiofrequency ablation in atrioventricular reciprocating tachycardia (AVRT).Methods: All patients undergoing cardiac electrophysiology and radiofrequency ablation procedures during the period from July, 2019 to July, 2021 at Department of Cardiology, Evercare Hospital, Dhaka were included in this study. The study analyzed 141 patients of among them 75(53.2%) patients were male and 66(46.8%) were female.Results: Patients who came with AVRT, 91 (65%) had concealed and 50 (35%) had manifested. The overall short term success rate was 99 %. There was no difference in the success rates between the younger and older patients. Complication rate is lower side of the spectrum, which is 1.4% (four patients).Conclusion: Radiofrequency ablation is a safe and successful treatment modality for patients with atrioventricular reciprocating tachycardia in this real - world study.Cardiovasc j 2022; 15(1): 20-25
背景:射频导管消融是治疗阵发性室上性心动过速的一种有效方法。本研究的目的是评价电生理治疗和射频消融治疗房室往复式心动过速(AVRT)的经验。方法:纳入2019年7月至2021年7月在达卡Evercare医院心内科接受心脏电生理和射频消融手术的所有患者。分析141例患者,其中男性75例(53.2%),女性66例(46.8%)。结果:在接受AVRT治疗的患者中,91例(65%)隐匿,50例(35%)出现。整体短期成功率为99%。年轻患者和老年患者的成功率没有差异。并发症发生率较低,为1.4%(4例)。结论:射频消融术是一种安全、成功的治疗房室往复式心动过速的方法。心血管病杂志[j] 2022;15 (1): 20 - 25
{"title":"Outcome in Cardiac Electrophysiology and Radiofrequency Ablation of Atrioventricular Reciprocating Tachycardia - A Single Center Experience","authors":"P. Bala, M. A. Ali, A. Reza, S. Talukder, S. Munwar, T. Ahmed, Kazi Atiqur Rahman, M. Khan, Nighat Islam, A. H. Bhuiyan, A. Islam, D. Afroz, Abeeda Tasnim Reza, Md Arifur Rahman, Aparajita Karim, Kanu Bala, M. Chaudhary","doi":"10.3329/cardio.v15i1.61906","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61906","url":null,"abstract":"Background: Radiofrequency catheter ablation is a curative modality of treatment for paroxysmal supraventricular tachycardia. The aim of our study was to evaluate our experience of electrophysiology procedures and radiofrequency ablation in atrioventricular reciprocating tachycardia (AVRT).\u0000Methods: All patients undergoing cardiac electrophysiology and radiofrequency ablation procedures during the period from July, 2019 to July, 2021 at Department of Cardiology, Evercare Hospital, Dhaka were included in this study. The study analyzed 141 patients of among them 75(53.2%) patients were male and 66(46.8%) were female.\u0000Results: Patients who came with AVRT, 91 (65%) had concealed and 50 (35%) had manifested. The overall short term success rate was 99 %. There was no difference in the success rates between the younger and older patients. Complication rate is lower side of the spectrum, which is 1.4% (four patients).\u0000Conclusion: Radiofrequency ablation is a safe and successful treatment modality for patients with atrioventricular reciprocating tachycardia in this real - world study.\u0000Cardiovasc j 2022; 15(1): 20-25","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77880553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brugada Syndrome in a Female Patient from Bangladesh: A Rare Occurrence Brugada综合征在孟加拉国女性患者:罕见的发生
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61916
D. Roychoudhury, J. Koruth
Brugada syndrome is inherited in an autosomal dominant pattern which is associated with ventricular fibrillation and sudden cardiac death in a patient with structurally normal heart. The diagnosis is clinched on characteristic EKG pattern of >2 mm ST segment elevation followed by negative T wave in right precordial leads V1,2 either occurring spontaneously or with pharmacological provocation with a sodium channel blocker. Prevalence of this disease varies by geographic location and sex with highest preponderance in South East Asian countries and in males. Among South-East Asian countries, there has been only one case report so far from Bangladesh and that too in a male patient. We present a case of female patient from Bangladesh with Brugada syndrome. We also report an association of Autism with Brugada syndrome in patient’s only female child.Cardiovasc j 2022; 15(1): 86-87
Brugada综合征以常染色体显性遗传模式遗传,与心脏结构正常患者的心室颤动和心源性猝死有关。诊断是通过特征性心电图模式确定的,ST段抬高> 2mm,右心前导联V1负T波,2可能是自发发生的,也可能是由钠通道阻滞剂引起的。该病的患病率因地理位置和性别而异,在东南亚国家和男性中发病率最高。在东南亚国家中,迄今为止孟加拉国只报告了一例病例,而且也是一名男性患者。我们报告一例来自孟加拉国的Brugada综合征女性患者。我们也报告自闭症与Brugada综合征在患者唯一的女孩的关联。心血管病杂志[j] 2022;15 (1): 86 - 87
{"title":"Brugada Syndrome in a Female Patient from Bangladesh: A Rare Occurrence","authors":"D. Roychoudhury, J. Koruth","doi":"10.3329/cardio.v15i1.61916","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61916","url":null,"abstract":"Brugada syndrome is inherited in an autosomal dominant pattern which is associated with ventricular fibrillation and sudden cardiac death in a patient with structurally normal heart. The diagnosis is clinched on characteristic EKG pattern of >2 mm ST segment elevation followed by negative T wave in right precordial leads V1,2 either occurring spontaneously or with pharmacological provocation with a sodium channel blocker. Prevalence of this disease varies by geographic location and sex with highest preponderance in South East Asian countries and in males. Among South-East Asian countries, there has been only one case report so far from Bangladesh and that too in a male patient. We present a case of female patient from Bangladesh with Brugada syndrome. We also report an association of Autism with Brugada syndrome in patient’s only female child.\u0000Cardiovasc j 2022; 15(1): 86-87","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84790644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Long-term Outcome between Diabetic and Non-Diabetic Patients with Ischemic Heart Disease following Percutaneous Coronary Intervention: A Prospective Study 糖尿病和非糖尿病缺血性心脏病患者经皮冠状动脉介入治疗后长期预后的比较:一项前瞻性研究
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61904
M. A. K. Akanda, Abeeda Tasnim Reza, Md Muhtasim Akanda, Md.Khyrul Kabir
Background: Diabetes Mellitus (DM) is an established independent predictor of adverse prognosis in patients undergoing percutaneous coronary intervention (PCI) even with improvements in diabetes treatment and interventional techniques. The aim of this study was to compare long term post PCI outcome between diabetic and non-diabetic patients with ischemic heart disease (IHD).Method: The data was derived from a prospective observational study to evaluate the outcome after PCI in DM patients for 2 years. A total of 305 patients with IHD & DM were randomly selected and enrolled who underwent PCI from 2010 to 2013 in an urban cardiac hospital of Bangladesh. The study population were divided into two groups with group 1 consisting of patients with DM (n=108) and group 2 of patients without DM (n=197). After the PCI, all patients were followed up for 2 years. The incidences of bleeding, stent thrombosis, myocardial infarction (MI), stroke and repeat revascularization were compared.Results: Diabetic patients had significant adverse outcomes having MI, stroke & MACCE respectively following 1 year (p= 0.018, 0.036 & 0.017) and MI following 2 years (p= 0.013) compared to non-diabetic patients. However, in multivariate analysis, diabetes mellitus was not found to be an independent predictor for 1-year & 2-year adverse events following PCI [OR 1.016 (0.317-3.259) & p 0.979, after 1 year and 1.554 (0.087 – 27.902) & p 0.765, after 2 years].Conclusions: The outcome of PCI after 1 year and 2 years among diabetic and non-diabetic subjects with IHD differed significantly in respect of MI, stroke & MACCE. But this study failed to identify diabetes mellitus as an independent risk factor for 1-year and 2-year adverse outcomes.Cardiovasc j 2022; 15(1): 5-12
背景:糖尿病(DM)是经皮冠状动脉介入治疗(PCI)患者不良预后的独立预测因素,即使糖尿病治疗和介入技术有所改善。本研究的目的是比较糖尿病和非糖尿病缺血性心脏病(IHD)患者PCI术后的长期预后。方法:数据来源于一项前瞻性观察研究,评估糖尿病患者PCI术后2年的预后。随机选取2010 - 2013年在孟加拉国某城市心脏医院行PCI治疗的IHD和DM患者305例。研究人群分为两组,第一组为糖尿病患者(n=108),第二组为非糖尿病患者(n=197)。PCI术后随访2年。比较两组支架内出血、支架内血栓形成、心肌梗死(MI)、卒中及重复血运重建术的发生率。结果:与非糖尿病患者相比,糖尿病患者在1年后分别发生心肌梗死、卒中和MACCE (p= 0.018、0.036和0.017),在2年后发生心肌梗死(p= 0.013)。然而,在多变量分析中,糖尿病并不是PCI术后1年和2年不良事件的独立预测因子[1年后OR 1.016 (0.317-3.259) & p 0.979, 2年后OR 1.554 (0.087 - 27.902) & p 0.765]。结论:糖尿病和非糖尿病IHD患者行PCI治疗1年和2年后的结果在心肌梗死、脑卒中和MACCE方面存在显著差异。但本研究未能确定糖尿病是1年和2年不良结局的独立危险因素。心血管病杂志[j] 2022;15 (1): 5 - 12
{"title":"Comparison of Long-term Outcome between Diabetic and Non-Diabetic Patients with Ischemic Heart Disease following Percutaneous Coronary Intervention: A Prospective Study","authors":"M. A. K. Akanda, Abeeda Tasnim Reza, Md Muhtasim Akanda, Md.Khyrul Kabir","doi":"10.3329/cardio.v15i1.61904","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61904","url":null,"abstract":"Background: Diabetes Mellitus (DM) is an established independent predictor of adverse prognosis in patients undergoing percutaneous coronary intervention (PCI) even with improvements in diabetes treatment and interventional techniques. The aim of this study was to compare long term post PCI outcome between diabetic and non-diabetic patients with ischemic heart disease (IHD).\u0000Method: The data was derived from a prospective observational study to evaluate the outcome after PCI in DM patients for 2 years. A total of 305 patients with IHD & DM were randomly selected and enrolled who underwent PCI from 2010 to 2013 in an urban cardiac hospital of Bangladesh. The study population were divided into two groups with group 1 consisting of patients with DM (n=108) and group 2 of patients without DM (n=197). After the PCI, all patients were followed up for 2 years. The incidences of bleeding, stent thrombosis, myocardial infarction (MI), stroke and repeat revascularization were compared.\u0000Results: Diabetic patients had significant adverse outcomes having MI, stroke & MACCE respectively following 1 year (p= 0.018, 0.036 & 0.017) and MI following 2 years (p= 0.013) compared to non-diabetic patients. However, in multivariate analysis, diabetes mellitus was not found to be an independent predictor for 1-year & 2-year adverse events following PCI [OR 1.016 (0.317-3.259) & p 0.979, after 1 year and 1.554 (0.087 – 27.902) & p 0.765, after 2 years].\u0000Conclusions: The outcome of PCI after 1 year and 2 years among diabetic and non-diabetic subjects with IHD differed significantly in respect of MI, stroke & MACCE. But this study failed to identify diabetes mellitus as an independent risk factor for 1-year and 2-year adverse outcomes.\u0000Cardiovasc j 2022; 15(1): 5-12","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88001424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between Microalbuminuria and Coronary Angiographic Severity in Non-diabetic Myocardial Infarction patients 非糖尿病性心肌梗死患者微量白蛋白尿与冠状动脉造影严重程度的相关性
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61911
Mohammad Mamoon Islam, Abdul Kader Akanda, M. Ullah, M. Alam, Md Gulam Mostofa, Md Zillur Rahman, Md Bonday Ali, Suchitra Basak
Background: Microalbuminuria may have an association with myocardial infarction in absence of traditional risk factors like diabetes. The present study was intended to find the association between microalbuminuria and angiographic severity of coronary artery disease in non-diabetic myocardial infarction patients.Methods: This cross sectional analytical study included 105 non-diabetic patients with myocardial infarction who underwent coronary angiography (CAG). The microalbuminuria was defined as urine albumin to creatinine ratio (ACR) of 30 -300 mg/g, while angiographic severity was measured by Gensini score with score e” 36 was taken as moderate to severe coronary artery disease (Group I) and score below 36 was termed as absent or mild coronary artery disease (Group II). Association of microalbuminuria with severity of coronary artery disease was determined.Results: Presence of microalbuminuria was found significantly higher (45%) in patients with moderate to severe coronary artery disease than that in patients with absent or mild CAD (4.6%). The Odds of having moderate to severe coronary artery disease in patients with microalbuminuria was observed to be 17 times (95% CI = 4.5 - 63) higher than that in patients without having this condition. Correlation between ACR and Gensini score was also found a significant positive relationship (r=0.702, p<0.001) with 70% of variation in Gensini score being explained by ACR.Conclusion: Microalbuminuria can be considered as a predictor of the severity of coronary artery disease in non-diabetic myocardial infarction patients.Cardiovasc j 2022; 15(1): 56-62
背景:在没有糖尿病等传统危险因素的情况下,微量白蛋白尿可能与心肌梗死有关。本研究旨在发现非糖尿病性心肌梗死患者微量白蛋白尿与冠状动脉病变血管造影严重程度之间的关系。方法:本横断面分析研究纳入了105例行冠状动脉造影(CAG)的非糖尿病心肌梗死患者。微量白蛋白尿定义为尿白蛋白与肌酐比值(ACR)为30 -300 mg/g,血管造影严重程度采用Gensini评分,评分为e, 36分为中度至重度冠状动脉疾病(I组),评分低于36分为无或轻度冠状动脉疾病(II组)。微量白蛋白尿与冠状动脉疾病严重程度的相关性。结果:中度至重度冠心病患者的微量白蛋白尿发生率(45%)明显高于无冠心病或轻度冠心病患者(4.6%)。微量白蛋白尿患者发生中度至重度冠状动脉疾病的几率是无微量白蛋白尿患者的17倍(95% CI = 4.5 - 63)。ACR与Gensini评分也呈显著正相关(r=0.702, p<0.001), 70%的Gensini评分变化可由ACR解释。结论:微量白蛋白尿可作为非糖尿病性心肌梗死患者冠状动脉疾病严重程度的预测指标。心血管病杂志[j] 2022;15 (1): 56 - 62
{"title":"Correlation between Microalbuminuria and Coronary Angiographic Severity in Non-diabetic Myocardial Infarction patients","authors":"Mohammad Mamoon Islam, Abdul Kader Akanda, M. Ullah, M. Alam, Md Gulam Mostofa, Md Zillur Rahman, Md Bonday Ali, Suchitra Basak","doi":"10.3329/cardio.v15i1.61911","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61911","url":null,"abstract":"Background: Microalbuminuria may have an association with myocardial infarction in absence of traditional risk factors like diabetes. The present study was intended to find the association between microalbuminuria and angiographic severity of coronary artery disease in non-diabetic myocardial infarction patients.\u0000Methods: This cross sectional analytical study included 105 non-diabetic patients with myocardial infarction who underwent coronary angiography (CAG). The microalbuminuria was defined as urine albumin to creatinine ratio (ACR) of 30 -300 mg/g, while angiographic severity was measured by Gensini score with score e” 36 was taken as moderate to severe coronary artery disease (Group I) and score below 36 was termed as absent or mild coronary artery disease (Group II). Association of microalbuminuria with severity of coronary artery disease was determined.\u0000Results: Presence of microalbuminuria was found significantly higher (45%) in patients with moderate to severe coronary artery disease than that in patients with absent or mild CAD (4.6%). The Odds of having moderate to severe coronary artery disease in patients with microalbuminuria was observed to be 17 times (95% CI = 4.5 - 63) higher than that in patients without having this condition. Correlation between ACR and Gensini score was also found a significant positive relationship (r=0.702, p<0.001) with 70% of variation in Gensini score being explained by ACR.\u0000Conclusion: Microalbuminuria can be considered as a predictor of the severity of coronary artery disease in non-diabetic myocardial infarction patients.\u0000Cardiovasc j 2022; 15(1): 56-62","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"141 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76183423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Neutrophil to Lymphocyte Ratio with In- hospital Outcome of Acute Heart Failure due to Acute Anterior ST-elevation Myocardial Infarction 中性粒细胞与淋巴细胞比值与急性st段抬高型心肌梗死致急性心力衰竭的院内预后的关系
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61905
Suchitra Basak, M. A. K. Akanda, M. Ullah, Sushanta Barua, M. Hasan, Md Shazedur Rahman, Mohammad Mamoon Islam, Md Gulam Mostafa
Background: Early detection and appropriate management play a key role in reducing the morbidity and mortality of acute heart failure in patients with acute myocardial infarction. Many prognostic factors have been assessed till date. This study aimed to evaluate the prognostic effect of NLR on in-hospital outcomes in patients with acute heart failure due to acute anterior ST elevation myocardial infarction.Methods: The present study was carried out in the Department of cardiology, Sir Salimullah Medical College & Mitford Hospital, Dhaka from January 2020 to December 2020. A total of 88 cases of acute heart failure due to acute anterior ST elevation Myocardial infarction patients are enrolled in this study. NLR was estimated and patients were divided into two groups based on the NLR (Group I NLR <6; Group II NLR ≥6). Then in-hospital outcome was observed and compared between two groups.Results: In-hospital mortality and length of hospital stay were higher among NLR ≥6 patients with statistical significance (11.6% vs. 40.9%, p<0.001). These patients also had high incidence of cardiogenic shock (25% vs. 43%, p>0.072), Arrhythmia (18% vs. 34%, p>0.089) but without statistically significant difference.Conclusion: In this study, we observed that in-hospital outcomes were worse in patients with acute heart failure due to acute anterior myocardial infarction with NLR ≥6. So NLR can be used as a predictor of outcome in acute heart failure patients. This association is independent of conventional cardiovascular risk factors.Cardiovasc j 2022; 15(1): 13-19
背景:早期发现和适当处理对降低急性心梗患者急性心衰的发病率和死亡率起着关键作用。迄今为止已经评估了许多预后因素。本研究旨在评估NLR对急性ST前抬高型心肌梗死致急性心力衰竭患者住院预后的影响。方法:本研究于2020年1月至2020年12月在达卡Sir Salimullah医学院和Mitford医院心内科进行。本研究共纳入88例急性ST前抬高型心肌梗死患者。估计NLR,根据NLR (I组NLR为0.072)、心律失常(18% vs. 34%, p>0.089)将患者分为两组,差异无统计学意义。结论:在本研究中,我们观察到NLR≥6的急性前路心肌梗死致急性心力衰竭患者的住院预后较差。因此NLR可以作为急性心力衰竭患者预后的预测指标。这种关联与传统的心血管危险因素无关。心血管病杂志[j] 2022;15 (1): 13 - 19
{"title":"Association of Neutrophil to Lymphocyte Ratio with In- hospital Outcome of Acute Heart Failure due to Acute Anterior ST-elevation Myocardial Infarction","authors":"Suchitra Basak, M. A. K. Akanda, M. Ullah, Sushanta Barua, M. Hasan, Md Shazedur Rahman, Mohammad Mamoon Islam, Md Gulam Mostafa","doi":"10.3329/cardio.v15i1.61905","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61905","url":null,"abstract":"Background: Early detection and appropriate management play a key role in reducing the morbidity and mortality of acute heart failure in patients with acute myocardial infarction. Many prognostic factors have been assessed till date. This study aimed to evaluate the prognostic effect of NLR on in-hospital outcomes in patients with acute heart failure due to acute anterior ST elevation myocardial infarction.\u0000Methods: The present study was carried out in the Department of cardiology, Sir Salimullah Medical College & Mitford Hospital, Dhaka from January 2020 to December 2020. A total of 88 cases of acute heart failure due to acute anterior ST elevation Myocardial infarction patients are enrolled in this study. NLR was estimated and patients were divided into two groups based on the NLR (Group I NLR <6; Group II NLR ≥6). Then in-hospital outcome was observed and compared between two groups.\u0000Results: In-hospital mortality and length of hospital stay were higher among NLR ≥6 patients with statistical significance (11.6% vs. 40.9%, p<0.001). These patients also had high incidence of cardiogenic shock (25% vs. 43%, p>0.072), Arrhythmia (18% vs. 34%, p>0.089) but without statistically significant difference.\u0000Conclusion: In this study, we observed that in-hospital outcomes were worse in patients with acute heart failure due to acute anterior myocardial infarction with NLR ≥6. So NLR can be used as a predictor of outcome in acute heart failure patients. This association is independent of conventional cardiovascular risk factors.\u0000Cardiovasc j 2022; 15(1): 13-19","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75904173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Glycosylated Haemoglobin as a Predictor of Severity of Coronary Artery Disease in Non-diabetic NSTEMI Patients 糖化血红蛋白作为非糖尿病非stemi患者冠状动脉疾病严重程度预测因子的评估
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61907
Md Gulam Mostofa, Abdul Kader Akanda, M. Ullah, Md Zillur Rahman, Mohammad Mamoon Islam, M. Alam, Md. Ahsanul Haque, Suchitra Basak
Background: Glycated hemoglobin (HbA1c) values reflect two to three months average endogenous exposure haemoglobin to glucose including postprandial spikes and have low intra-individual variability particularly in non-diabetic patients. Elevated HbA1c is regarded as an independent risk factor for coronary artery disease (CAD) in patients with or without diabetes mellitus (DM). The purpose of this study is to determine the correlation between the level of HbA1c and the severity of coronary artery disease in non-diabetic non ST elevation myocardial infarction (NSTEMI) patients.Methods: This observational study was carried out with total of 64 non-diabetic patients with a history of NSTEMI. Patients were divided into 2 groups based on HbA1c - one group having HbA1c ³5.7 – 6.4% (High risk group) and another group with HbA1c < 5.7% (Low risk group). Severity of CAD was assessed using Gensini score derived from coronary angiographic data. Gensini score < 36 points was regarded as mild coronary artery disease and Gensini score 36 points as moderate to severe coronary artery disease. Then patients with high and low risk HbA1C groups were correlated with severity of CAD.Results: Over 55.5% patients with HbA1c in high-risk group (5.7 – 6.4%) had severe CAD as opposed to 28.6% patients with HbA1c in low-Risk group (<5.7%). The individuals with high-risk group of HbA1c was 3.1 (95% of CI = 1.1 – 8.9) times more likely to have severe CAD than those with HbA1c < 5.7% (p = 0.031). Spearman correlation between HbA1c and Gensini score depicted that the two variables exhibit a linear relationship indicating that Gensini score rises parallel with the rise of HbA1c (r = 0.289, p = 0.021).Conclusion: The study concluded that over half of the non-diabetic, NSTEMI patients with high-risk range HbA1c are likely to have severe CAD than those with HBA1c within normal range.Cardiovasc j 2022; 15(1): 26-35
背景:糖化血红蛋白(HbA1c)值反映了2 - 3个月平均内源性血红蛋白对葡萄糖的暴露,包括餐后峰值,个体内变异性较低,特别是在非糖尿病患者中。HbA1c升高被认为是合并或不合并糖尿病(DM)患者冠状动脉疾病(CAD)的独立危险因素。本研究旨在探讨非糖尿病性非ST段抬高型心肌梗死(NSTEMI)患者HbA1c水平与冠状动脉疾病严重程度的相关性。方法:本观察性研究共纳入64例非糖尿病且有非stemi病史的患者。根据HbA1c分为两组,一组HbA1c³5.7 ~ 6.4%(高危组),另一组HbA1c < 5.7%(低危组)。采用冠状动脉造影数据得出的Gensini评分来评估冠心病的严重程度。Gensini评分< 36分为轻度冠状动脉病变,Gensini评分36分为中重度冠状动脉病变。然后HbA1C高危组和低危组患者与冠心病严重程度相关。结果:超过55.5%的HbA1c高危组患者(5.7 - 6.4%)有严重的CAD,而28.6%的HbA1c低危组患者(<5.7%)有严重的CAD。HbA1c高危组发生严重冠心病的可能性是HbA1c < 5.7%组的3.1倍(95% CI = 1.1 ~ 8.9) (p = 0.031)。HbA1c与Gensini评分的Spearman相关性表明,两者呈线性关系,Gensini评分与HbA1c的升高同步升高(r = 0.289, p = 0.021)。结论:在HbA1c高危范围的非糖尿病、非stemi患者中,超过一半的患者比HbA1c正常范围的患者更容易发生严重的CAD。心血管病杂志[j] 2022;15(1): 26 - 35周不等
{"title":"Evaluation of the Glycosylated Haemoglobin as a Predictor of Severity of Coronary Artery Disease in Non-diabetic NSTEMI Patients","authors":"Md Gulam Mostofa, Abdul Kader Akanda, M. Ullah, Md Zillur Rahman, Mohammad Mamoon Islam, M. Alam, Md. Ahsanul Haque, Suchitra Basak","doi":"10.3329/cardio.v15i1.61907","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61907","url":null,"abstract":"Background: Glycated hemoglobin (HbA1c) values reflect two to three months average endogenous exposure haemoglobin to glucose including postprandial spikes and have low intra-individual variability particularly in non-diabetic patients. Elevated HbA1c is regarded as an independent risk factor for coronary artery disease (CAD) in patients with or without diabetes mellitus (DM). The purpose of this study is to determine the correlation between the level of HbA1c and the severity of coronary artery disease in non-diabetic non ST elevation myocardial infarction (NSTEMI) patients.\u0000Methods: This observational study was carried out with total of 64 non-diabetic patients with a history of NSTEMI. Patients were divided into 2 groups based on HbA1c - one group having HbA1c ³5.7 – 6.4% (High risk group) and another group with HbA1c < 5.7% (Low risk group). Severity of CAD was assessed using Gensini score derived from coronary angiographic data. Gensini score < 36 points was regarded as mild coronary artery disease and Gensini score 36 points as moderate to severe coronary artery disease. Then patients with high and low risk HbA1C groups were correlated with severity of CAD.\u0000Results: Over 55.5% patients with HbA1c in high-risk group (5.7 – 6.4%) had severe CAD as opposed to 28.6% patients with HbA1c in low-Risk group (<5.7%). The individuals with high-risk group of HbA1c was 3.1 (95% of CI = 1.1 – 8.9) times more likely to have severe CAD than those with HbA1c < 5.7% (p = 0.031). Spearman correlation between HbA1c and Gensini score depicted that the two variables exhibit a linear relationship indicating that Gensini score rises parallel with the rise of HbA1c (r = 0.289, p = 0.021).\u0000Conclusion: The study concluded that over half of the non-diabetic, NSTEMI patients with high-risk range HbA1c are likely to have severe CAD than those with HBA1c within normal range.\u0000Cardiovasc j 2022; 15(1): 26-35","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77745572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between QRS duration on ECG and Left Ventricular Systolic Function by Echocardiography in patients with Non-ST elevated Myocardial Infarction 非st段抬高型心肌梗死患者心电图QRS时间与超声心动图左心室收缩功能的关系
Pub Date : 2022-10-10 DOI: 10.3329/cardio.v15i1.61908
M. Z. Rahman, Abdul Kader Akanda, M. Ullah, Md. Shariful Alam, Md Gulam Mostofa, Mohammad Mamoon Islam, Md. Iqbal Hossain, Md. Ahsanul Haque
Background: Early risk stratification of patients with myocardial infarction is critical to determine optimum treatment strategies and enhance outcomes. The present study was therefore undertaken to determine the relationship between QRS duration (QRSd) on admission ECG and left ventricular ejection fraction (LVEF) as a measure of left ventricular function in non-ST elevated myocardial infarction (NSTEMI) patients.Methods: This observational study was carried out from January to December 2020 with total of 120 patients with a history of NSTEMI. Based on the cut-off value of QRS duration 100 msec, the patients were divided into two groups – one group with QRS duration d” 100 msec (normal QRS) and another group with QRS duration > 100 msec (prolonged QRS). Left ventricular systolic function was considered preserved, if it was e” 52% and reduced if it was < 52%. The association and correlation between QRS duration and LVEF was then observed.Results: The prevalence of reduced LVEF in patients with prolonged QRS duration (> 100 msec) was double (38%) than that of preserved (19.5%). The risk of having LV dysfunction in patients with prolonged QRS duration was 2.5 (95% CI = 1.1 – 6.2) times higher than that in patients normal QRS duration (d” 100 msec) (p = 0.039). The QRS duration and LVEF bear a significantly inverse relationship (r = -0.341, p < 0.001). The sensitivity of prolonged QRS duration (> 100 msec) in correctly detecting LV dysfunction was inappreciably low (38%), although its specificity in excluding those who did not have LV dysfunction was optimum (80.5%) with overall diagnostic accuracy being 52.5%.Conclusion: Prolonged QRS duration on a standard 12-lead ECG is associated with reduced echocardiographic LVEF. However, QRS duration in predicting LV dysfunction is much less sensitive, although its specificity is optimum indicating that QRS duration is not a good predictor of LV dysfunction (reduced LVEF), but it can dependably predict those who do not have LV dysfunction (preserved LVEF).Cardiovasc j 2022; 15(1): 36-41
背景:心肌梗死患者的早期风险分层对于确定最佳治疗策略和提高预后至关重要。因此,本研究旨在确定入院心电图上QRS持续时间(QRSd)与左心室射血分数(LVEF)之间的关系,LVEF是衡量非st段升高型心肌梗死(NSTEMI)患者左心室功能的指标。方法:本观察性研究于2020年1月至12月进行,共120例有NSTEMI病史的患者。根据QRS持续时间截断值100 msec,将患者分为QRS持续时间≥100 msec组(正常QRS)和QRS持续时间> 100 msec组(延长QRS)。当左心室收缩功能为0.52%时,认为左心室收缩功能保留;当左心室收缩功能< 52%时,认为左心室收缩功能降低。然后观察QRS持续时间与LVEF之间的相关性。结果:QRS持续时间延长(> 100 msec)患者LVEF降低的发生率(38%)是保留患者(19.5%)的两倍。QRS持续时间延长的患者发生左室功能障碍的风险是QRS持续时间正常(d“100 msec)患者的2.5倍(95% CI = 1.1 - 6.2) (p = 0.039)。QRS持续时间与LVEF呈显著负相关(r = -0.341, p < 0.001)。QRS持续时间延长(> 100 msec)在正确检测左室功能障碍方面的敏感性非常低(38%),尽管它在排除无左室功能障碍的患者方面的特异性是最佳的(80.5%),总体诊断准确率为52.5%。结论:标准12导联心电图QRS持续时间延长与超声心动图LVEF降低相关。然而,QRS持续时间在预测左室功能障碍方面的敏感性要低得多,尽管其特异性最佳,表明QRS持续时间不能很好地预测左室功能障碍(LVEF减少),但它可以可靠地预测无左室功能障碍(LVEF保留)的患者。心血管病杂志[j] 2022;15 (1): 36-41
{"title":"Relationship between QRS duration on ECG and Left Ventricular Systolic Function by Echocardiography in patients with Non-ST elevated Myocardial Infarction","authors":"M. Z. Rahman, Abdul Kader Akanda, M. Ullah, Md. Shariful Alam, Md Gulam Mostofa, Mohammad Mamoon Islam, Md. Iqbal Hossain, Md. Ahsanul Haque","doi":"10.3329/cardio.v15i1.61908","DOIUrl":"https://doi.org/10.3329/cardio.v15i1.61908","url":null,"abstract":"Background: Early risk stratification of patients with myocardial infarction is critical to determine optimum treatment strategies and enhance outcomes. The present study was therefore undertaken to determine the relationship between QRS duration (QRSd) on admission ECG and left ventricular ejection fraction (LVEF) as a measure of left ventricular function in non-ST elevated myocardial infarction (NSTEMI) patients.\u0000Methods: This observational study was carried out from January to December 2020 with total of 120 patients with a history of NSTEMI. Based on the cut-off value of QRS duration 100 msec, the patients were divided into two groups – one group with QRS duration d” 100 msec (normal QRS) and another group with QRS duration > 100 msec (prolonged QRS). Left ventricular systolic function was considered preserved, if it was e” 52% and reduced if it was < 52%. The association and correlation between QRS duration and LVEF was then observed.\u0000Results: The prevalence of reduced LVEF in patients with prolonged QRS duration (> 100 msec) was double (38%) than that of preserved (19.5%). The risk of having LV dysfunction in patients with prolonged QRS duration was 2.5 (95% CI = 1.1 – 6.2) times higher than that in patients normal QRS duration (d” 100 msec) (p = 0.039). The QRS duration and LVEF bear a significantly inverse relationship (r = -0.341, p < 0.001). The sensitivity of prolonged QRS duration (> 100 msec) in correctly detecting LV dysfunction was inappreciably low (38%), although its specificity in excluding those who did not have LV dysfunction was optimum (80.5%) with overall diagnostic accuracy being 52.5%.\u0000Conclusion: Prolonged QRS duration on a standard 12-lead ECG is associated with reduced echocardiographic LVEF. However, QRS duration in predicting LV dysfunction is much less sensitive, although its specificity is optimum indicating that QRS duration is not a good predictor of LV dysfunction (reduced LVEF), but it can dependably predict those who do not have LV dysfunction (preserved LVEF).\u0000Cardiovasc j 2022; 15(1): 36-41","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"135 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82985809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pattern and Extent of Coronary Artery Disease in Patients of Ischemic Heart Disease aged 40 Years or less 40岁以下缺血性心脏病患者冠状动脉病变的模式和范围
Pub Date : 2022-04-06 DOI: 10.3329/cardio.v14i2.58774
M. Ahmed, Solaiman Hossain, M. S. Alam, Md. Shahimur Parvez, Debashish Debnath, Md Mahidur Rahman Khan
Background: Atherosclerotic coronary artery disease is rare in young adults aged 40 years or less. However, South Asia is among the top 3 of the countries with highest proportion of cases of first acute coronary syndrome events occurring at age 40 years or less. This study was to explore the extent and pattern of angiographic coronary artery disease among patients of ischemic heart disease aged 40 years or less.Methods: This cross-sectional retrospective descriptive study included 140 patients who had coronary angiography for ischemic heart disease at the Department of Cardiology of Enam Medical College between July 2012 and December 2020. Coronary angiography was analyzed with particular attention to the extent of involvement of major epicardial coronary arteries including significant branch involvement.Results: Of the 140 patients included in the study - aged 18-40 years (mean 35.90 and SD 4.05) and 59.28% in the 36-40 years age group – 85% were male. Coronary angiogram revealed Single Vessel Disease in 39.29%, Double Vessel Disease in 25.72%, Triple Vessel disease in 23.57%, normal Coronaries in 9.28%. Left Anterior descending territory was most involved - 94 (67.14%) patients having significant stenosis in the main trunk and/or one or more major branches. Overall, 23(16.43%) of the whole cohort of patients had multiple branch involvements in the three coronary artery territories.Conclusion: In patients aged up to 40 years with ischemic heart disease, significant coronary artery disease burden was seen, including a significant proportion with multi-vessel disease and a high level of branch involvement in all the principal epicardial coronary territories. This indicates a high burden of disease in a relatively young age group, with significant implications for long term management over and beyond reperfusion/revascularization efforts.Cardiovasc j 2022; 14(2): 103-110
背景:动脉粥样硬化性冠状动脉疾病在40岁以下的年轻人中很少见。然而,南亚是40岁或以下首次急性冠状动脉综合征事件病例比例最高的三个国家之一。本研究旨在探讨40岁以下缺血性心脏病患者冠状动脉造影病变的范围和模式。方法:本横断面回顾性描述性研究纳入了2012年7月至2020年12月在伊纳姆医学院心内科接受缺血性心脏病冠状动脉造影的140例患者。冠状动脉造影分析,特别注意主要心外膜冠状动脉的受累程度,包括重要的分支受累。结果:纳入研究的140例患者(18-40岁,平均35.90,标准差4.05)和36-40岁年龄组59.28%)中,85%为男性。冠状动脉造影显示单支病变占39.29%,双支病变占25.72%,三支病变占23.57%,冠状动脉正常占9.28%。左侧前降区受累最多,94例(67.14%)患者有主干和/或一个或多个主干狭窄。总体而言,整个队列中有23例(16.43%)患者在三个冠状动脉区域有多个分支受累。结论:在40岁以下的缺血性心脏病患者中,可以看到明显的冠状动脉疾病负担,包括多血管疾病的显著比例和所有主要心外膜冠状动脉区域的高水平分支累及。这表明,在相对年轻的年龄组中,疾病负担很高,这对再灌注/血运重建工作之外的长期管理具有重要意义。心血管病杂志[j] 2022;14 (2): 103 - 110
{"title":"Pattern and Extent of Coronary Artery Disease in Patients of Ischemic Heart Disease aged 40 Years or less","authors":"M. Ahmed, Solaiman Hossain, M. S. Alam, Md. Shahimur Parvez, Debashish Debnath, Md Mahidur Rahman Khan","doi":"10.3329/cardio.v14i2.58774","DOIUrl":"https://doi.org/10.3329/cardio.v14i2.58774","url":null,"abstract":"Background: Atherosclerotic coronary artery disease is rare in young adults aged 40 years or less. However, South Asia is among the top 3 of the countries with highest proportion of cases of first acute coronary syndrome events occurring at age 40 years or less. This study was to explore the extent and pattern of angiographic coronary artery disease among patients of ischemic heart disease aged 40 years or less.\u0000Methods: This cross-sectional retrospective descriptive study included 140 patients who had coronary angiography for ischemic heart disease at the Department of Cardiology of Enam Medical College between July 2012 and December 2020. Coronary angiography was analyzed with particular attention to the extent of involvement of major epicardial coronary arteries including significant branch involvement.\u0000Results: Of the 140 patients included in the study - aged 18-40 years (mean 35.90 and SD 4.05) and 59.28% in the 36-40 years age group – 85% were male. Coronary angiogram revealed Single Vessel Disease in 39.29%, Double Vessel Disease in 25.72%, Triple Vessel disease in 23.57%, normal Coronaries in 9.28%. Left Anterior descending territory was most involved - 94 (67.14%) patients having significant stenosis in the main trunk and/or one or more major branches. Overall, 23(16.43%) of the whole cohort of patients had multiple branch involvements in the three coronary artery territories.\u0000Conclusion: In patients aged up to 40 years with ischemic heart disease, significant coronary artery disease burden was seen, including a significant proportion with multi-vessel disease and a high level of branch involvement in all the principal epicardial coronary territories. This indicates a high burden of disease in a relatively young age group, with significant implications for long term management over and beyond reperfusion/revascularization efforts.\u0000Cardiovasc j 2022; 14(2): 103-110","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72652780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Percutaneous Coronary Intervention of ST-segment Elevated Myocardial Infarction- Experiences in a Tertiary Care Hospital 经皮冠状动脉介入治疗st段抬高型心肌梗死的临床经验
Pub Date : 2022-04-06 DOI: 10.3329/cardio.v13i2.52969
A. Islam, S. Munwar, S. Talukder, A. Reza, A. H. Bhuiyan, T. Ahmed, Kazi Atiqur Rahman, M. A. Ali, Shamsul Alam, Z. Rahman, I. Yusuf, Nighat Islam, M. Hasan, A. B. Siddique, P. Bala, M. Z. Haque, MS Alam, H. Tanvir
Background: Primary percutaneous coronary intervention (pPCI) is the preferred and established mode of treatment in ST elevated myocardial infarction (STEMI). Exact data on procedural outcome in patient undergoing primary PCI in our population is not well documented. Therefore, we have carried out this study to see the prognosis, in-hospital, and 12-month survival outcome of our patients. Methods: Patients were enrolled in the observational non-randomized prospective cohort between November 2017-Mar 2020, who were presented into our emergency department with acute onset of severe chest pain or angina with ECG evidenced acute ST elevated myocardial infarction. Total 182 patient (F 14; Male 168) were enrolled in this study. Results: Out of 182 patients, female :14 (7.7%) vs. Male: 168 (92.3%). Among, these patient females were more obese (BMI: Female 27.1 ± 2.1 vs. male 25.8 ± 4.1) and developed CAD in advance age (Female 59.1 ± 13.5 vs. Male 53.7 ± 10.5). Anterior MI were 47.8% (n=87) and Inferior MI 50.5% (n=92) and Lateral MI 1.6% (n=3). At presentation 10.4% (n=19) patents were in cardiogenic shock with STEMI, 42.1%(n=8) patients with Ant MI, 57.9%(n=11) in Inf MI group. Total, 15 (8.2%) patients died; 93.3%(n=14) within 1 week of pPCI due shock and poor LV function and subsequent development of LVF with arrhythmia and 6.7%(n=1) patient died 6 months after pPCI due to other cause. Death was more in Ant Wall STEMI than Inferior wall STEMI, though Cardiogenic shock at presentation were more in Inf MI STEMI than Ant wall STEMI. Conclusion: We may conclude from our observational study on STEMI PCI that the territory wise involvement of myocardium, baseline serum Troponin-I level, infarcted vessel, time to presentation, duration of anginal chest pain and door to balloon time may be the key determinant of better in hospital outcome. Cardiovasc. j. 2021; 13(2): 154-163
背景:原发性经皮冠状动脉介入治疗(pPCI)是ST段升高型心肌梗死(STEMI)首选的治疗方法。在我们的人群中,接受初级PCI的患者的手术结果的确切数据没有很好的记录。因此,我们进行了这项研究,以了解患者的预后、住院和12个月的生存结果。方法:2017年11月至2020年3月期间,患者被纳入观察性非随机前瞻性队列,这些患者因急性发作的严重胸痛或心绞痛,心电图显示急性ST段升高心肌梗死而进入急诊科。182例患者(14例;168名男性被纳入本研究。结果:182例患者中,女性14例(7.7%),男性168例(92.3%)。其中,女性肥胖者较多(BMI:女性27.1±2.1比男性25.8±4.1),且出现冠心病的年龄较早(女性59.1±13.5比男性53.7±10.5)。前路心肌梗死为47.8% (n=87),下路心肌梗死为50.5% (n=92),外侧心肌梗死为1.6% (n=3)。10.4% (n=19)患者为STEMI心源性休克,42.1%(n=8)患者为Ant MI, 57.9%(n=11)患者为Inf MI组。死亡15例(8.2%);93.3%(n=14)患者在pPCI后1周内因休克、左室功能差并发左室f并发心律失常,6.7%(n=1)患者在pPCI后6个月因其他原因死亡。蚂蚁壁STEMI患者的死亡率高于下壁STEMI患者,而心源性休克患者的死亡率高于蚂蚁壁STEMI患者。结论:从STEMI PCI的观察性研究中,我们可以得出结论,心肌的浸润范围、基线血清肌钙蛋白- 1水平、梗死血管、出现时间、心绞痛性胸痛持续时间和门到球囊时间可能是医院预后较好的关键决定因素。Cardiovasc。j。2021;13 (2): 154 - 163
{"title":"Primary Percutaneous Coronary Intervention of ST-segment Elevated Myocardial Infarction- Experiences in a Tertiary Care Hospital","authors":"A. Islam, S. Munwar, S. Talukder, A. Reza, A. H. Bhuiyan, T. Ahmed, Kazi Atiqur Rahman, M. A. Ali, Shamsul Alam, Z. Rahman, I. Yusuf, Nighat Islam, M. Hasan, A. B. Siddique, P. Bala, M. Z. Haque, MS Alam, H. Tanvir","doi":"10.3329/cardio.v13i2.52969","DOIUrl":"https://doi.org/10.3329/cardio.v13i2.52969","url":null,"abstract":"Background: Primary percutaneous coronary intervention (pPCI) is the preferred and established mode of treatment in ST elevated myocardial infarction (STEMI). Exact data on procedural outcome in patient undergoing primary PCI in our population is not well documented. Therefore, we have carried out this study to see the prognosis, in-hospital, and 12-month survival outcome of our patients. \u0000Methods: Patients were enrolled in the observational non-randomized prospective cohort between November 2017-Mar 2020, who were presented into our emergency department with acute onset of severe chest pain or angina with ECG evidenced acute ST elevated myocardial infarction. Total 182 patient (F 14; Male 168) were enrolled in this study. \u0000Results: Out of 182 patients, female :14 (7.7%) vs. Male: 168 (92.3%). Among, these patient females were more obese (BMI: Female 27.1 ± 2.1 vs. male 25.8 ± 4.1) and developed CAD in advance age (Female 59.1 ± 13.5 vs. Male 53.7 ± 10.5). Anterior MI were 47.8% (n=87) and Inferior MI 50.5% (n=92) and Lateral MI 1.6% (n=3). At presentation 10.4% (n=19) patents were in cardiogenic shock with STEMI, 42.1%(n=8) patients with Ant MI, 57.9%(n=11) in Inf MI group. Total, 15 (8.2%) patients died; 93.3%(n=14) within 1 week of pPCI due shock and poor LV function and subsequent development of LVF with arrhythmia and 6.7%(n=1) patient died 6 months after pPCI due to other cause. Death was more in Ant Wall STEMI than Inferior wall STEMI, though Cardiogenic shock at presentation were more in Inf MI STEMI than Ant wall STEMI. \u0000Conclusion: We may conclude from our observational study on STEMI PCI that the territory wise involvement of myocardium, baseline serum Troponin-I level, infarcted vessel, time to presentation, duration of anginal chest pain and door to balloon time may be the key determinant of better in hospital outcome. \u0000Cardiovasc. j. 2021; 13(2): 154-163","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87941880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Coronary Intervention of Bifurcation Lesion 经皮冠状动脉介入治疗分叉病变
Pub Date : 2022-04-06 DOI: 10.3329/cardio.v14i2.58782
A. Islam, S. Talukder, S. Munwar, A. Reza, T. Ahmed, K. Rahman
Bifurcation lesion whether it is left main (LM) stem disease with left main to left anterior descending artery (LM-LAD) or left main to left circumflex (LM-LCX), LAD-Diagonal or LCX-Obtuse marginal or right coronary artery- posterior descending artery (RCA-PDA); are not uncommon lesion type that needs to be revascularized either by percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) to establish the coronary flow and relieved patient anginal symptoms. Even though, many of the literature maintained non-inferiority of bifurcation lesion PCI over CABG and is Class IIb indication for PCI by coronary stent. In literature, bifurcation lesions commonly encountered in PCI and are regarded as most technically challenging lesions to treat, in up to 20% of PCI cases. With the advent of interventional procedures and the availability of cardiac catheterization laboratory facilities, skilled interventionist, many of the Bangladeshi patients are being treated for coronary artery diseases (CAD). With the advent of drug eluting stents, availability of IVUS (Intravascular Ultrasound), FFR (Fractional Flow Reserve) and individual expertise, treating bifurcation lesion may not be difficult task. Interventionist must be expert enough in doing PCI, before to proceed for bifurcation lesion PCI. We need to work together to develop common consensus in developing updated skill in treating bifurcation lesion which will prove bifurcation PCI in our population.Cardiovasc j 2022; 14(2): 168-175
分叉病变是否为左主干(LM)病变伴左主干至左前降支(LM- lad)或左主干至左旋支(LM- lcx)、左主干-斜向或左主干-钝缘或右冠状动脉-后降支(RCA-PDA);并非罕见的病变类型,需要经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)来重建冠状动脉血流并缓解患者心绞痛症状。尽管如此,许多文献仍然认为分叉病变PCI优于CABG,并且是冠状动脉支架PCI的IIb级指征。在文献中,分岔病变常见于PCI,并且被认为是治疗技术上最具挑战性的病变,在多达20%的PCI病例中。随着介入手术的出现和心导管化验室设施、熟练的介入医生的出现,许多孟加拉国病人正在接受冠状动脉疾病的治疗。随着药物洗脱支架的出现,IVUS(血管内超声),FFR(分数血流储备)的可用性和个人专业知识,治疗分叉病变可能不是一项困难的任务。介入医师在进行分叉病变PCI之前,必须对PCI有足够的专业知识。我们需要共同努力,在发展治疗分叉病变的最新技术方面达成共识,这将证明我们人群中的分叉PCI。心血管病杂志[j] 2022;14 (2): 168 - 175
{"title":"Percutaneous Coronary Intervention of Bifurcation Lesion","authors":"A. Islam, S. Talukder, S. Munwar, A. Reza, T. Ahmed, K. Rahman","doi":"10.3329/cardio.v14i2.58782","DOIUrl":"https://doi.org/10.3329/cardio.v14i2.58782","url":null,"abstract":"Bifurcation lesion whether it is left main (LM) stem disease with left main to left anterior descending artery (LM-LAD) or left main to left circumflex (LM-LCX), LAD-Diagonal or LCX-Obtuse marginal or right coronary artery- posterior descending artery (RCA-PDA); are not uncommon lesion type that needs to be revascularized either by percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) to establish the coronary flow and relieved patient anginal symptoms. Even though, many of the literature maintained non-inferiority of bifurcation lesion PCI over CABG and is Class IIb indication for PCI by coronary stent. In literature, bifurcation lesions commonly encountered in PCI and are regarded as most technically challenging lesions to treat, in up to 20% of PCI cases. With the advent of interventional procedures and the availability of cardiac catheterization laboratory facilities, skilled interventionist, many of the Bangladeshi patients are being treated for coronary artery diseases (CAD). With the advent of drug eluting stents, availability of IVUS (Intravascular Ultrasound), FFR (Fractional Flow Reserve) and individual expertise, treating bifurcation lesion may not be difficult task. Interventionist must be expert enough in doing PCI, before to proceed for bifurcation lesion PCI. We need to work together to develop common consensus in developing updated skill in treating bifurcation lesion which will prove bifurcation PCI in our population.\u0000Cardiovasc j 2022; 14(2): 168-175","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":"236 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73888467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1